Rahoto kan sakamakon kudi na kamfanin Kiniksa Pharmaceuticals, Ltd., Kiniksa Pharmaceuticals, Ltd. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Kiniksa Pharmaceuticals, Ltd. buga rahotanni na kudi?
Kiniksa Pharmaceuticals, Ltd. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a US dollar a yau
Kiniksa Pharmaceuticals, Ltd. kudaden shiga na lokutan rahotonnin da suka gabata. Kiniksa Pharmaceuticals, Ltd. kudaden shiga na yau shine 0 $. Thearfin kuɗin shiga na Kiniksa Pharmaceuticals, Ltd. ya canza ta 4 173 000 $ a cikin 'yan shekarun nan. Kiniksa Pharmaceuticals, Ltd. ginshiƙi akan rahoton hada-hadar kudi ta yanar gizo. Kiniksa Pharmaceuticals, Ltd. rahoton rahoton kuɗi akan allon yana nuna ƙarfin dukiya. Dukkanin bayani game da Kiniksa Pharmaceuticals, Ltd. jimlar kudaden shiga akan wannan ginshiƙi an ƙirƙira su ta hanyar sanduna masu rawaya.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Zamanin Kiniksa Pharmaceuticals, Ltd. rahotannin kudi: 31/12/2018, 31/12/2020, 31/03/2021. Kwanan bayanan bayanan kuɗi ana ƙaddara su ta hanyar dokokin lissafi. Kwanan kwanan rahoton rahoton kuɗi na Kiniksa Pharmaceuticals, Ltd. na yau shine 31/03/2021. Ribar kuɗi Kiniksa Pharmaceuticals, Ltd. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Kiniksa Pharmaceuticals, Ltd. ne -49 484 000 $
Dates na kudi rahotanni Kiniksa Pharmaceuticals, Ltd.
31/03/2021
31/12/2020
30/09/2020
30/06/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
-
-
-
-
-
-
-
-
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
-
-
-
-
-
-
-
-
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
-
-
-
-
-
-
-
-
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
-
-
-
-
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-49 283 000 $
-52 898 000 $
-43 218 000 $
-31 860 000 $
-30 446 000 $
-39 289 000 $
-67 647 000 $
-44 135 000 $
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-49 484 000 $
-53 657 000 $
-43 836 000 $
-37 469 000 $
-27 058 000 $
-37 191 000 $
-65 821 000 $
-42 580 000 $
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
28 683 000 $
38 552 000 $
31 048 000 $
21 931 000 $
21 622 000 $
30 400 000 $
58 830 000 $
35 901 000 $
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
49 283 000 $
52 898 000 $
43 218 000 $
31 860 000 $
30 446 000 $
39 289 000 $
67 647 000 $
44 135 000 $
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
275 564 000 $
333 249 000 $
378 413 000 $
264 493 000 $
268 340 000 $
296 458 000 $
334 956 000 $
313 750 000 $
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
311 158 000 $
349 464 000 $
384 413 000 $
271 441 000 $
281 805 000 $
308 137 000 $
346 159 000 $
321 965 000 $
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
119 856 000 $
114 038 000 $
85 874 000 $
123 456 000 $
68 809 000 $
82 810 000 $
82 629 000 $
71 976 000 $
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
-
-
-
-
27 560 000 $
30 178 000 $
36 892 000 $
42 554 000 $
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
-
-
-
-
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
-
-
-
-
29 894 000 $
32 940 000 $
39 640 000 $
42 698 000 $
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
-
-
-
-
10.61 %
10.69 %
11.45 %
13.26 %
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
270 696 000 $
311 935 000 $
358 509 000 $
250 416 000 $
251 911 000 $
275 197 000 $
306 519 000 $
279 267 000 $
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-
-
-
-
-29 267 000 $
-41 676 000 $
-63 256 000 $
-27 638 000 $
Rahoton kudi na baya-bayan nan game da kudin shiga na Kiniksa Pharmaceuticals, Ltd. shine ranar 31/03/2021. A cewar sabon rahoto game da sakamakon kudi na Kiniksa Pharmaceuticals, Ltd., yawan kudaden da Kiniksa Pharmaceuticals, Ltd. ya samu ya kai 0 US dollar kuma ya canza zuwa 0% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Kiniksa Pharmaceuticals, Ltd. a cikin kwata na karshe shine -49 484 000 $, karuwar riba ta karu da 0% idan aka kwatanta da bara.
Kudin hannun jari Kiniksa Pharmaceuticals, Ltd.
Kudin hannun jari Kiniksa Pharmaceuticals, Ltd.
Sharorin Kiniksa Pharmaceuticals, Ltd. a yau, farashin kayayyaki KNSA yana da layi yanzu.
Rahoto kan sakamakon kudi na kamfanin Kiniksa Pharmaceuticals, Ltd., Kiniksa Pharmaceuticals, Ltd. shekara-shekara na samun kudin shiga ga shekara ta 2024.
